Anesthesiology, Pain Medicine · McKinney, TX
NPI
1174636435
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
5605 Virginia Pkwy Ste 3
McKinney, TX, 75071
Phone (469) 452-2024
Groups this clinician bills Medicare through
Medicare paid, 2024
$494K
23,264 services
Medicare patients, 2024
314
Average age 73
Drug cost, 2024
$283K
2,159 prescriptions
Company payments, 2025
$1,473
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed I Ali was code J1010 (injection, methylprednisolone acetate, 1 mg), 17,320 times for 119 patients. In total Syed I Ali billed 23,264 services in 79 codes, and Medicare paid $494K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 17,320 | 119 | $0.10 | $1,744 |
| 99214 Office E&M - Established | Office | 998 | 202 | $90.88 | $91K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 508 | 55 | $0.09 | $45.17 |
| 80307 Drug Tests | Office | 495 | 139 | $59.69 | $30K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 493 | 139 | $186.55 | $92K |
| 96136 Behavioral Health Services | Office | 488 | 250 | $29.71 | $14K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 405 | 156 | $0.29 | $116 |
| 99213 Office E&M - Established | Office | 277 | 130 | $64.29 | $18K |
| 99204 Office E&M - New | Office | 133 | 133 | $121.42 | $16K |
| 93922 Duplex Scan - Extremity Arteries | Office | 132 | 126 | $59.11 | $7,802 |
| 62323 Nerve Block Injection - Back | Office | 81 | 47 | $180.02 | $15K |
| 64493 Nerve Block Injection - Back | Office | 72 | 38 | $192.56 | $14K |
| 64494 Nerve Block Injection - Back | Office | 71 | 37 | $100.94 | $7,167 |
| 20610 Joint Injection | Office | 69 | 36 | $52.23 | $3,604 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 69 | 40 | $302.33 | $21K |
By year: 2022 $560K for 10,472 services; 2023 $476K for 8,653 services; 2024 $494K for 23,264 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 495 | 139 | $59.69 | $30K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 493 | 139 | $186.55 | $92K |
Medicare prescription drug claims, 2024
In 2024, the drug Syed I Ali prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 694 prescriptions and refills. In total Syed I Ali wrote 2,159 Medicare prescriptions that cost $283K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 694 | 694 | 138 | $18K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 218 | 218 | 47 | $5,813 |
| Pregabalin Generic | 171 | 217 | 70 | $3,856 |
| Tramadol Hcl Generic | 126 | 126 | 32 | $811 |
| Gabapentin Generic | 97 | 141 | 33 | $1,715 |
| Tizanidine Hcl Generic | 93 | 148 | 52 | $1,714 |
| Xtampza Er Oxycodone Myristate | 92 | 92 | 25 | $31K |
| Morphine Sulfate Generic | 54 | 54 | Under 11 | $1,076 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 49 | 49 | Under 11 | $1,304 |
| Oxycodone Hcl Generic | 49 | 49 | 12 | $573 |
| Methadone Hcl Generic | 44 | 44 | Under 11 | $567 |
| Belbuca Buprenorphine Hcl | 43 | 43 | 20 | $16K |
| Naloxone Hcl Generic | 33 | 44 | 29 | $2,020 |
| Duloxetine Hcl Generic | 33 | 51 | 18 | $461 |
| Celecoxib Generic | 29 | 45 | Under 11 | $645 |
Brand drugs: 266 claims; generic drugs: 1,893 claims; opioid claims: 1,454.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed I Ali $1,473 ($1,473 in general payments such as food, travel and fees) from 15 companies. The largest payer was Forte Bio-Pharma LLC with $434.
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 24 | $434 |
| Medtronic, Inc. MDT | 13 | $178 |
| Pfizer Inc. PFE | 15 | $144 |
| Saluda Medical Americas, Inc. | 4 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $111 |
| Scilex Pharmaceuticals Inc. | 6 | $104 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $67.02 |
| Protega Pharmaceutials Inc | 2 | $63.96 |
| Si-Bone, Inc. SIBN | 3 | $63.61 |
| Abbvie Inc. ABBV | 2 | $40.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.